查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611183

全球感染疾病物市場規模、佔有率和趨勢分析報告：按類型、給藥途徑、分銷管道、地區和細分市場進行預測（2025-2030年）

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

感染疾病物市場成長及趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球感染疾病物市場規模將達到1,449.6億美元，2025年至2030年複合年成長率為1.61%。 HIV、H1N1 和伊波拉病毒等感染疾病的日益流行反映了近幾十年來社區行為模式的重大變化。社會變遷以及醫療保健專業人員和患者意識的提高正在推動成長。

世界衛生組織 (WHO) 和疾病管制與預防中心 (CDC) 等治療組織正在積極努力提高公眾對感染疾病致命影響和早期治療重要性的認知。 CDC 正在與國家衛生署(NHM) 合作，在巴西、中國、奈及利亞和印度等開發中國家宣傳傳染病並加強對感染疾病的治療。

然而，研發線產品的商業化，例如功效和功效增強的新治療藥物的推出以及 2018 年細胞週期蛋白作為社區獲得性細菌性肺炎（CABP）治療藥物的商業化，預計將推動感染疾病。的成長。

感染疾病物市場報告亮點

  • 由於 HIV 藥物 vicriviroc 等新型強效抗病毒藥物價格高昂，預計抗病毒藥物將成為最大的細分市場，到 2024 年，其市場佔有率將達到 50.9%。
  • 抗病毒藥物是感染疾病物市場的重要組成部分，主要用於治療和預防病毒感染。
  • 2024年8月，鹽野義株式會社宣布，新藥認證（NDA）被中國藥品審查中心受理。頭孢菌素針對革蘭氏陰性菌，包括多重抗藥性菌株，在 III 期試驗中顯示出比Imipenem/西司他丁更優越的功效。
  • 到 2024 年，院內藥局將以 48.5% 的最高收益佔有率主導市場，而電子商務預計將成為預測期內成長最快的領域。
  • 2024年，北美地區在全球產業中佔據主導地位，佔最大佔有率，佔總收益的38.1%。兒童和成人感染疾病（包括醫院感染）的高盛行率以及由此導致的抗生素過度使用和非處方箋感染疾病物的獲取增加是主要促進因素。
  • 由於對新藥的大量未滿足的需求、醫療保健基礎設施的快速改善以及醫療保健專業人員和患者的意識不斷提高，亞太地區是成長最快的區域之一。
  • 有效的疾病管理需要多種長期策略，包括新產品開發、併購、共同開發和業務擴張。例如，2024年1月，Basilea Pharmaceutica宣布從Spexis AG收購臨床前抗生素計畫。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章感染疾病物市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 附隨市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 感染疾病物市場分析工具
    • 波特五力分析
    • PESTLE分析

第4章感染疾病物市場 - 細分分析：按類型（2018-2030）

  • 感染疾病市場：類型變異分析
  • 按類型
    • 抗菌劑
    • 抗病毒藥物
    • 抗真菌藥物

第5章感染疾病物市場 - 細分分析：依給藥途徑（2018-2030）

  • 感染疾病物市場：給藥途徑變異分析
  • 依給藥途徑
    • 局部的
    • 口服
    • 胃腸外的
    • 其他

第6章感染疾病物市場 - 細分分析：按分銷管道（2018-2030）

  • 感染疾病品市場：通路波動分析
  • 按分銷管道
    • 醫院藥房
    • 零售藥房
    • 其他

第7章感染疾病物市場：按類型、給藥途徑和分銷管道分類的區域估計和趨勢分析

  • 感染疾病物市場：區域前景
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與企業
  • 參與企業概況
  • 財務表現
  • 產品基準
  • 公司市場定位分析：2024年
  • 主要企業簡介
    • Pfizer Inc.
    • Bayer AG
    • AbbVie
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb
    • Merck &Co., Inc.
    • Sandoz International GmbH
    • B. Braun SE
    • Xellia Pharmaceuticals
    • Mankind Pharma
    • AstraZeneca
    • Boehringer Ingelheim International GmbH

第9章結論

Product Code: 978-1-68038-973-9

Anti-Infective Agents Market Growth & Trends:

The global anti-infective agents market size is estimated to reach USD 144.96 billion by 2030, expanding at a CAGR of 1.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of infectious diseases such as HIV, H1N1, and Ebola virus reflect the profound changes in behavioral patterns of communities over the recent decades. The societal changes and increasing awareness among healthcare professionals and patients are driving the growth.

Organizations, such as the World Health Organization (WHO) and Centers for Disease control and Prevention (CDC) are actively involved in spreading awareness amongstpeople regarding the fatal implications of infectious diseases and the importance of early treatment. The CDC has collaborated with the National Health Ministry (NHM) in an attempt to spread awareness and to enhance the treatment of communicable diseases in developing countries such as Brazil, China, Nigeria, and India.

However, introduction of novel therapeutics with increased potency and efficacy and the commercialization of pipeline products, such as commercialization of Omadacycline in 2018 for the treatment of Community Acquired Bacterial Pneumonia (CABP), are expected to propel the growth of the anti-infective agents market.

Anti-Infective Agents Market Report Highlights:

  • Antiviral was estimated to be the largest segment with a market share of 50.9% in 2024 owing to the high price associated with the new potent anti-viral drugs, such as Vicriviroc for the treatment of HIV
  • Antiviral segment dominated the market with a 50.9% share in 2024. Antiviral drugs are crucial components of the anti-infective agents market, primarily used in the treatment and prevention of viral infections
  • In August 2024, Shionogi & Co. announced that its New Drug Application (NDA) for cefiderocol, a novel siderophore cephalosporin antibiotic, has been accepted for review in China by the Center for Drug Evaluation. Cefiderocol targets gram-negative bacteria, including multidrug-resistant strains, and has demonstrated superior efficacy in a Phase III trial compared to imipenem/cilastatin.
  • Hospital pharmacy dominated the market with the highest revenue share of 48.5% in 2024 while e-commerce is expected to be the fastest-growing segment during the forecast period
  • North America dominated the global industry in 2024 and accounted for the largest share of 38.1% of the overall revenue. High prevalence of infectious diseases including hospital-acquired infections in both, children and adults, and the resultant overuse of antibiotics coupled with increased accessibility of non-prescription anti-infectives are the major drivers
  • Asia Pacific is one of the fastest growing regional segments owing to the presence of high, unmet demand for novel drugs, rapid improvements in healthcare infrastructure coupled with rising awareness among healthcare professionals and patients
  • Effective disease management involves a range of long-term strategies such as new product development, mergers and acquisitions, co-development, and business expansions. For instance, in January 2024, Basilea Pharmaceutica announced its acquisition of a preclinical antibiotics program from Spexis AG.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Market Definitions
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Epidemiology-Based Market Analysis
      • 1.7.1.1 Approach 1: Epidemiology-Based Approach
      • 1.7.1.2 Approach 2: Commodity Flow Approach
      • 1.7.1.3 Approach 2: Revenue share analysis Using Bottom-up Approach
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Research Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 By Type and Route of Administration Snapshot
  • 2.3 By Distribution Channel Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Anti-infective Agents Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing Incidence Of Targeted Diseases
      • 3.2.1.2 Growing Investments On R&D Activities Of Anti-Infective Drugs
      • 3.2.1.3 Rise In Initiatives For The Awareness Of Infectious Diseases
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Emergence of Resistance to Anti-infective Drugs and Adverse Effects Associated with them
  • 3.3 Anti-infective Agents Market Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestle Analysis

Chapter 4 Anti-infective Agents Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 4.1 Anti-infective Agents Market: Type Movement Analysis
  • 4.2 Anti-infective Agents Market Estimates & Forecast, By Type (USD Million)
    • 4.2.1 Antibacterials
      • 4.2.1.1 Cephalosporins
      • 4.2.1.2 Penicillin
      • 4.2.1.3 Fluoroquinolones
      • 4.2.1.4 Macrolides
      • 4.2.1.5 Carbapenem
      • 4.2.1.6 Others
    • 4.2.2 Antivirals
    • 4.2.3 Antifungals
      • 4.2.3.1 Azoles
      • 4.2.3.2 Echinocandins
      • 4.2.3.3 Polyenes
      • 4.2.3.4 Others

Chapter 5 Anti-infective Agents Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

  • 5.1 Anti-infective Agents Market: Route of Administration Movement Analysis
  • 5.2 Anti-infective Agents Market Estimates & Forecast, By Route of Administration (USD Million)
    • 5.2.1 Topical
    • 5.2.2 Oral
    • 5.2.3 Parental
    • 5.2.4 Others

Chapter 6 Anti-infective Agents Market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Anti-infective Agents Market: Distribution Channel Movement Analysis
  • 6.2 Anti-infective Agents Market Estimates & Forecast, By Distribution Channel (USD Million)
    • 6.2.1 Hospital Pharmacies
    • 6.2.2 Retail Pharmacies
    • 6.2.3 Others

Chapter 7 Anti-infective Agents Market: Regional Estimates and Trend Analysis by Type, Route of Administration, and Distribution Channel

  • 7.1 Anti-infective Agents Market: Regional Outlook
  • 7.2 North America
    • 7.2.1 North America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 U.S. Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.2.2.3 Competitive/Market Scenario
      • 7.2.2.4 Regulatory Framework
      • 7.2.2.5 Reimbursement Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Canada Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.2.3.3 Competitive/Market Scenario
      • 7.2.3.4 Regulatory Framework
      • 7.2.3.5 Reimbursement Scenario
    • 7.2.4 Mexico
      • 7.2.4.1 Key Country Dynamics
      • 7.2.4.2 Mexico Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.2.4.3 Competitive/Market Scenario
      • 7.2.4.4 Regulatory Framework
      • 7.2.4.5 Reimbursement Scenario
  • 7.3 Europe
    • 7.3.1 Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 UK Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.2.3 Competitive/Market Scenario
      • 7.3.2.4 Regulatory Framework
      • 7.3.2.5 Reimbursement Scenario
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Germany Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.3.3 Competitive/Market Scenario
      • 7.3.3.4 Regulatory Framework
      • 7.3.3.5 Reimbursement Scenario
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 France Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.4.3 Competitive/Market Scenario
      • 7.3.4.4 Regulatory Framework
      • 7.3.4.5 Reimbursement Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Italy Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.5.3 Competitive/Market Scenario
      • 7.3.5.4 Regulatory Framework
      • 7.3.5.5 Reimbursement Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Spain Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.6.3 Competitive/Market Scenario
      • 7.3.6.4 Regulatory Framework
      • 7.3.6.5 Reimbursement Scenario
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Denmark Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.7.3 Competitive/Market Scenario
      • 7.3.7.4 Regulatory Framework
      • 7.3.7.5 Reimbursement Scenario
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Sweden Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.8.3 Competitive/Market Scenario
      • 7.3.8.4 Regulatory Framework
      • 7.3.8.5 Reimbursement Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Norway Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.9.3 Competitive/Market Scenario
      • 7.3.9.4 Regulatory Framework
      • 7.3.9.5 Reimbursement Scenario
    • 7.3.10 Rest Of Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Japan Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.2.3 Competitive/Market Scenario
      • 7.4.2.4 Regulatory Framework
      • 7.4.2.5 Reimbursement Scenario
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 China Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.3.3 Competitive/Market Scenario
      • 7.4.3.4 Regulatory Framework
      • 7.4.3.5 Reimbursement Scenario
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 India Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.4.3 Competitive/Market Scenario
      • 7.4.4.4 Regulatory Framework
      • 7.4.4.5 Reimbursement Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Australia Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.5.3 Competitive/Market Scenario
      • 7.4.5.4 Regulatory Framework
      • 7.4.5.5 Reimbursement Scenario
    • 7.4.6 Thailand
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Thailand Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.6.3 Competitive/Market Scenario
      • 7.4.6.4 Regulatory Framework
      • 7.4.6.5 Reimbursement Scenario
    • 7.4.7 South Korea
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 South Korea Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.4.7.3 Competitive/Market Scenario
      • 7.4.7.4 Regulatory Framework
      • 7.4.7.5 Reimbursement Scenario
    • 7.4.8 Rest Of Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Brazil Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.5.2.3 Competitive/Market Scenario
      • 7.5.2.4 Regulatory Framework
      • 7.5.2.5 Reimbursement Scenario
    • 7.5.3 Argentina
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Argentina Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.5.3.3 Competitive/Market Scenario
      • 7.5.3.4 Regulatory Framework
      • 7.5.3.5 Reimbursement Scenario
    • 7.5.4 Rest Of Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 South Africa Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.3 Competitive/Market Scenario
      • 7.6.2.4 Regulatory Framework
      • 7.6.2.5 Reimbursement Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Saudi Arabia Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.3 Competitive/Market Scenario
      • 7.6.3.4 Regulatory Framework
      • 7.6.3.5 Reimbursement Scenario
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 UAE Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.6.4.3 Competitive/Market Scenario
      • 7.6.4.4 Regulatory Framework
      • 7.6.4.5 Reimbursement Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Kuwait Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.6.5.3 Competitive/Market Scenario
      • 7.6.5.4 Regulatory Framework
      • 7.6.5.5 Reimbursement Scenario
    • 7.6.6 Rest Of MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Participant Categorization
  • 8.2 Participant's Overview
  • 8.3 Financial Performance
  • 8.4 Product Benchmarking
  • 8.5 Company Market Positioning Analysis, 2024
  • 8.6 Key Company Profiles
    • 8.6.1. Pfizer Inc.
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Bayer AG
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. AbbVie
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Gilead Sciences, Inc.
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Bristol-Myers Squibb
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Merck & Co., Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Sandoz International GmbH
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. B. Braun SE
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Xellia Pharmaceuticals
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. Mankind Pharma
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. AstraZeneca
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives
    • 8.6.12. Boehringer Ingelheim International GmbH
      • 8.6.12.1. Company overview
      • 8.6.12.2. Financial performance
      • 8.6.12.3. Product benchmarking
      • 8.6.12.4. Strategic initiatives

Chapter 9 Conclusion

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
  • Table 4 North America Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 North America Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 North America Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 U.S. Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 U.S. Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 Canada Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 Canada Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 Mexico Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Mexico Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Europe Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 UK Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 UK Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 UK Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 France Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 France Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 France Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Spain Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Spain Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Spain Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Denmark Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Sweden Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Norway Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Norway Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Norway Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Japan Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Japan Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 50 Japan Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 China Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 India Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 India Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 India Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea Anti-Infective Agents Market, By Type 2018 - 2030 (USD Million)
  • Table 58 South Korea Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 59 South Korea Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Australia Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 Australia Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Thailand Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Thailand Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Thailand Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Latin America Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 Latin America Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Brazil Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 72 Brazil Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Argentina Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Argentina Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Argentina Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 South Africa Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 South Africa Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Africa Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 UAE Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 87 UAE Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 UAE Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research approaches
  • Fig. 2 Value chain-based sizing & forecasting
  • Fig. 3 Market formulation & validation
  • Fig. 4 Anti-Infective Agents market segmentation
  • Fig. 5 Market driver analysis (current & future impact)
  • Fig. 6 Market restraint analysis (current & future impact)
  • Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 8 Porter's five forces analysis
  • Fig. 9 Anti-Infective Agents market: Type outlook and key takeaways
  • Fig. 10 Anti-Infective Agents market: Type movement analysis
  • Fig. 11 Antibacterials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 12 Antivirals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Antifungals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cephalosporins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Penicillins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Fluoroquinolones market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Macrolides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Carbapenems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Azoles market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Echinocandins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Polyenes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Anti-Infective Agents market: Route of administration outlook and key takeaways
  • Fig. 24 Anti-Infective Agents market: Route of administration movement analysis
  • Fig. 25 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Anti-Infective Agents market: Distribution channel outlook and key takeaways
  • Fig. 28 Anti-Infective Agents market: Distribution channel movement analysis
  • Fig. 29 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Research Centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 North America Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 MEA Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 List of key emerging company's/disruptors/innovators